Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy

Thirty-two patients with cerebral adrenoleukodystrophy received lentiviral gene therapy, and after a median of 6 years most were free of major disability. Myelodysplastic syndrome developed in one patient.

​   The New England Journal of Medicine: Search Results in Neurology/Neurosurgery